STAT
OCTOBER 25, 2023
Oncologists were more likely to provide low-value cancer care after receiving money from pharmaceutical companies, and the findings raise questions about the extent to which industry influence may have led to patient harm, according to a new study. Continue to STAT+ to read the full story…
The FDA Law Blog
MARCH 18, 2025
In the generic filers view, the regulatory review period should have started in January 2014 when the patent was reissued rather than in April 2004, when the IND was opened, because the reissued patent did not exist in April 2004. The plain text of 35 U.S.C. The Court thus explained that interpreting the patent in 35 U.S.C.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 17, 2022
“Combining EraCal’s phenotypic screening platform with Novo Nordisk’s expertise within pharmaceutical peptides and metabolic diseases will contribute to the discovery of novel drug candidates for the treatment of obesity,” said Josua Jordi, CEO of EraCal. “We
pharmaphorum
NOVEMBER 10, 2021
Success, then, will rely on an integrated response that focuses on surveillance, stewardship, and intervention accessibility across the spectrum of human, animal, and environmental health, said the report, which was commissioned to assess the progress of the 2014 National Strategy for Combating Antibiotic-Resistant Bacteria. Surveillance.
pharmaphorum
NOVEMBER 17, 2020
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. In 2014 Keith was fortunate to become a full-time salaried patient research ambassador at Liverpool Heart and Chest Hospital Trust.
European Pharmaceutical Review
AUGUST 23, 2022
Second, pharmaceutical companies can implement serialisation of individual medicines, potentially tracking and tracing medicines to ensure brand protection. We believe that we need more scientists and researchers to work effectively at the intersection of academia, pharmaceutical companies and government agencies.
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
Expert insights. Personalized for you.
145 
Let's personalize your content